Ingelfinger JR, Kalantar-Zadeh K, Schaefer F

Idioma: Español
Referencias bibliográficas: 36
Paginas: 71-75
Archivo PDF: 680.53 Kb.

FRAGMENTO

El Día Mundial del Riñón 2016 se enfoca en las enfermedades renales durante la infancia y en los antecedentes de la enfermedad renal del adulto que puede iniciar en la edad temprana. La Enfermedad Renal Crónica (ERC) en la infancia difiere de la de los adultos en que predominan las causas derivadas de anomalías congénitas y trastornos hereditarios, siendo poco frecuentes las glomerulopatías y la enfermedad renal asociada a diabetes. Adicionalmente, muchos niños con Injuria Renal Aguda pueden eventualmente desarrollar secuelas que lleven a hipertensión y ERC durante la adolescencia o la vida adulta. Los niños nacidos prematuros o pequeños para la edad gestacional tienen un incremento del riesgo para desarrollar ERC durante su vida.
Personas con alto riesgo al nacer o en la primera infancia, deberán ser monitorizados estrechamente para ayudar a detectar a tiempo signos tempranos de enfermedad renal a fin de proporcionar una prevención o tratamiento efectivos. Una terapia exitosa es factible para niños con ERC avanzada; existe evidencia que demuestra que los niños evolucionan mejor que los adultos cuando reciben terapia de reemplazo renal, incluyendo diálisis y trasplante, aunque solo una minoría de los niños puede requerir este tratamiento.
Debido a las inequidades en el acceso a la atención médica, es necesario hacer un esfuerzo para que los niños con enfermedad renal, donde sea que vivan, puedan ser tratados de manera eficaz, independientemente de su ubicación geográfica y situación y económica. Nuestra esperanza es que el Día Mundial del Riñón pueda informar al público en general, a los tomadores de decisiones y a los profesionales de la salud, sobre las necesidades y las posibilidades que existen alrededor de la enfermedad renal en la infancia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.Goldstein, S.L. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 33, 131-137 (2012).

2. 2.Harambat, J., van Stralen, K.J., et al. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27, 363-373 (2012).

3. 3.Warady, B.A. & Chadha, V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol 22, 1999-2009 (2007).

4. 4.Furth, S.L., y cols. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1, 1006-1015 (2006).

5. 5.Health statistics and information systems: Estimates for 2000–2012.Disponible en: http://www.who.int/healthinfo/global_burden_di sease/estimates/en/index1.html.

6. 6.NAPRTCS Annual Reports. Disponible en: https://web.emmes.com/study/ped/annlrept/ann lrept.html.

7. 7.Saran, R., y cols. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 65, A7 (2015).

8. 8.ESPN/ERA-EDTA Registry, European Registry for Childrenon Renal Replacement Therapy http://www.espn-reg.org/index.jsp.

9. 9.Ardissino, G., y cols. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111, e382-387 (2003).

10. 10.Wong, C.J., Moxey-Mims, M., et al. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60, 1002-1011 (2012).

11. 11.Global Burden of Disease Stud y 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 386, 743-800 (2013).

12. 12.Coca, S.G., Singanamala, S. & Parikh, C.R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81, 442-448 (2012).

13. 13.Basu, R.K., y cols. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 16, 24 (2015).

14. 14.Eckardt, K.U., y cols. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158-169 (2013).

15. 15.Wuhl, E., y cols. Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 8, 67-74 (2013).

16. 16.Group, E.T., y cols. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361, 1639-1650 (2009).

17. 17.Van Stralen, K.J., et al. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 86(2014).

18. 18.Querfeld, U., y cols. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 5, 1642-1648 (2010).

19. 19.Hoy, W.E., y cols. The early development of the kidney and implications for future health. Journal of developmental origins of health and disease 1, 216-233 (2010).

20. 20.Flynn, J.T., y cols. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 165, 154-162 e151 (2014).

21. 21.Rodriguez, M.M., y cols. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatric and developmental pathology : 7, 17-25 (2004).

22. 22.Abitbol, C.L., y cols. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 18, 887-893 (2003)

23. 23.Hodgin, J.B., Rasoulpour, M., et al. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4, 71-76 (2009).

24. 24.Verhave, J.C., Wetzels, J.F. & van de Kar, N.C. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant 29 Suppl 4, iv131-141 (2014).

25. 25.Torres, V.E. Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu Rev Med 66, 195-210 (2015).

26. 26.Jarzembowski, T., y cols. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 8, 367-371 (2004).

27. 27.Watson, A.R. Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14, 469-472 (2000).

28. 28.Aujoulat, I., y cols. Non-adherence in adolescent transplant recipients: the role of uncertainty in health care providers. Pediatr Transplant 15, 148-156 (2011).

29. 29.Watson, A.R., y cols. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int 80, 704-707 (2011).

30. 30.Watson, A.R., y cols. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol 26, 1753-1757 (2011).

31. 31.Gallieni, M., y cols. The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project. The Scientific World Journal 2014, 320869 (2014).

32. 32.White, A., Wong, W., Sureshkumur, P. & Singh, G. The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease. Journal of paediatrics and child health 46, 504-509 (2010).

33. 33.Zarocostas, J. Need to increase focus on noncommunicable diseases in global health, says WHO. BMJ 341, c7065 (2010).

34. 34.Gulland, A. WHO agrees to set up body to act on non-communicable diseases. BMJ 346, f3483 (2013).

35. 35.Feehally, J. Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol 8, 12-13 (2011).

36. 36.Couser, W.G., Remuzzi, G., Mendis, S. & Tonelli, M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80, 1258-1270 (2011).